Oncology became the most valuable therapy area in 2010 and has grown rapidly over the last decade. The continued launch of innovative medicines is .. Read more one of the key drivers fueling this growth and many new launches are targeted therapies that stem from a better understanding of tumor biology and therapy mechanism of action. However, the rate of innovation has not been the same across tumor types. Whilst some oncology diseases saw an improvement in standard of care thanks to the emergence of new product classes, unmet needs still exist across many others. This webinar will provide a deeper, more granular view of the oncology market using MIDAS Sales by Disease linked to global cancer statistics and detail key developments that have changed the landscape.
- Share your Experience